Suchergebnisse - "Uchino, Junji"

PubPharm (15)

1

A phase 2 trial of durvalumab treatment following radiation monotherapy in patients with non-small cell lung cancer ineligible for stage III chemoradiotherapy : The SPIRAL-RT study

enthalten in: European journal of cancer (Oxford, England : 1990) | 2023

von Yamada, T. | Goto, Y. | Tanaka, H. | +9

2

Prophylactic treatment of dacomitinib-induced skin toxicities in epidermal growth factor receptor-mutated non-small-cell lung cancer : A multicenter, Phase II trial

enthalten in: Cancer medicine | 2023

von Iwasaku, M. | Uchino, J. | Chibana, K. | +16

3

Ramucirumab Plus Docetaxel for Patients with Non-small cell Lung Cancer with Brain Metastases : A Multicenter, Open-Label Single-Arm Phase II Trial

enthalten in: The oncologist | 2023

von Tanimura, K. | Uchino, J. | Kimura, H. | +11

4

A Phase II Trial on Osimertinib as a First-Line Treatment for EGFR Mutation-Positive Advanced NSCLC in Elderly Patients : The SPIRAL-0 Study

enthalten in: The oncologist | 2022

von Chihara, Y. | Takeda, T. | Goto, Y. | +20

ErratumIn: Oncologist. 2024 Mar 18;:. - PMID 38498842

5

Randomized Phase II Study of First-Line Biweekly Gemcitabine and Carboplatin Versus Biweekly Gemcitabine and Carboplatin plus Maintenance Gemcitabine in Elderly Patients with Untreated Non-Small Cell Lung Cancer : LOGIK0801

enthalten in: The oncologist | 2020

von Takayama, K. | Takeshita, M. | Inoue, K. | +9

6

Phase II Study on Biweekly Combination Therapy of Gemcitabine plus Carboplatin for the Treatment of Elderly Patients with Advanced Non-Small Cell Lung Cancer

enthalten in: The oncologist | 2020

von Takayama, K. | Ichiki, M. | Matsumoto, T. | +6

7

Randomized Phase II Study of Weekly Paclitaxel plus Carboplatin Versus Biweekly Paclitaxel plus Carboplatin for Patients with Previously Untreated Advanced Non-Small Cell Lung Cancer

enthalten in: The oncologist | 2019

von Takayama, K. | Ichiki, M. | Tokunaga, S. | +4

8

Phase II Study of S-1 and Paclitaxel Combination Therapy in Patients with Previously Treated Non-Small Cell Lung Cancer

enthalten in: The oncologist | 2019

von Chihara, Y. | Yoshimura, A. | Date, K. | +12

9

Osimertinib in Elderly Patients with Epidermal Growth Factor Receptor T790M-Positive Non-Small-Cell Lung Cancer Who Progressed During Prior Treatment : A Phase II Trial

enthalten in: The oncologist | 2019

von Nakao, A. | Hiranuma, O. | Uchino, J. | +26

10

A Phase II Study of S-1 and Paclitaxel Combination Therapy as a First-Line Treatment in Elderly Patients with Advanced Non-Small Cell Lung Cancer

enthalten in: The oncologist | 2019

von Yoshimura, A. | Chihara, Y. | Date, K. | +10